Davern Capital Partners, Lp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$364.5M
Q ending 2026-03-31
Prior quarter
$309.3M
Q ending 2025-12-31
Change
+17.9% QoQ
Positions
17
reported holdings
Largest positions
All 17 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Pfizer Inc | PFE | Shares | $44.8M | 1.6M |
| Regeneron Pharmaceuticals | REGN | Shares | $34.6M | 45K |
| Insmed Inc | INSM | Shares | $29.9M | 183K |
| Ionis Pharmaceuticals Inc | IONS | Shares | $29.1M | 387K |
| Natera Inc | NTRA | Shares | $28.8M | 144K |
| Biontech Se | BNTX | Shares | $27.1M | 305K |
| Argenx Se | ARGX | Shares | $25.6M | 35K |
| Eli Lilly & Co | LLY | Shares | $25.1M | 27K |
| Royalty Pharma Plc | Shares | $24.9M | 520K | |
| Roivant Sciences Ltd | Shares | $24.2M | 873K | |
| Legend Biotech Corp | LEGN | Shares | $23.8M | 1.3M |
| Mineralys Therapeutics Inc | MLYS | Shares | $12.1M | 447K |
| Abivax Sa | ABVX | Shares | $8.7M | 78K |
| Generate Biomedicines Inc | GENB | Shares | $7.4M | 592K |
| Procept Biorobotics Corp | PRCT | Shares | $6.5M | 261K |
| Structure Therapeutics Inc | GPCR | Shares | $6.1M | 126K |
| Viridian Therapeutics Inc | VRDN | Shares | $5.9M | 302K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.